Inventor · disambiguated record
Shon Booker
Also filed as: BOOKER SHON · BOOKER SHON K · BOOKER SHON KEITH
38 granted patents·18 pending applications·790 citations·filing 2002–2025
98Inventor score
Top patents by PatentIndex Score
56 records- 0198US11993597B2Inhibitors of KRAS G12C and methods of using the sameAMGEN INC·Filed 2022·Granted May 28, 2024·8 cites·50 claims
- 0298US11905281B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2020·Granted Feb 20, 2024·13 cites·16 claims
- 0398US11766436B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2021·Granted Sep 26, 2023·11 cites·19 claims
- 0498US11306087B2Inhibitors of KRAS G12C and methods of using the sameAMGEN INC·Filed 2020·Granted Apr 19, 2022·16 cites·55 claims
- 0598US11090304B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2019·Granted Aug 17, 2021·33 cites·3 claims
- 0698US10640504B2Inhibitors of KRAS G12C and methods of using the sameAMGEN INC·Filed 2018·Granted May 5, 2020·50 cites·71 claims
- 0798US10532042B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2017·Granted Jan 14, 2020·49 cites·13 claims
- 0898US10519146B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2018·Granted Dec 31, 2019·81 cites·33 claims
- 0997US11285135B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2019·Granted Mar 29, 2022·20 cites·16 claims
- 1097US11096939B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2019·Granted Aug 24, 2021·24 cites·30 claims
- 1196US12083121B2Substituted piperazines as KRAS G12C inhibitorsAMGEN INC·Filed 2022·Granted Sep 10, 2024·7 cites·5 claims
- 1296US11285156B2Substituted piperazines as KRAS G12C inhibitorsAMGEN INC·Filed 2019·Granted Mar 29, 2022·16 cites·4 claims
- 1395US7652009B2Substituted heterocycles and methods of useAMGEN INC·Filed 2005·Granted Jan 26, 2010·33 cites·25 claims
- 1495US6878714B2Substituted alkylamine derivatives and methods of useAMGEN INC·Filed 2002·Granted Apr 12, 2005·85 cites·39 claims
- 1594US7820665B2Imidazopyridazine inhibitors of PI3 kinase for cancer treatmentAMGEN INC·Filed 2008·Granted Oct 26, 2010·38 cites·9 claims
- 1693US12440491B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2023·Granted Oct 14, 2025·1 cites·4 claims
- 1793US9066954B2Fused heterocyclic derivatives and methods of useAMGEN INC·Filed 2013·Granted Jun 30, 2015·22 cites·9 claims
- 1892US8524900B2Fused heterocyclic derivatives and methods of useALBRECHT BRIAN K·Filed 2011·Granted Sep 3, 2013·23 cites·8 claims
- 1992US7928140B2Benzothiazole PI3 kinase modulators for cancer treatmentAMGEN INC·Filed 2008·Granted Apr 19, 2011·32 cites·17 claims
- 2092US6995162B2Substituted alkylamine derivatives and methods of useAMGEN INC·Filed 2002·Granted Feb 7, 2006·48 cites·26 claims
- 2191US7858623B2Substituted amide derivatives and methods of useAMGEN INC·Filed 2006·Granted Dec 28, 2010·15 cites·5 claims
- 2291US7435823B2Compounds and methods of useAMGEN INC·Filed 2005·Granted Oct 14, 2008·19 cites·23 claims
- 2391US7102009B2Substituted amine derivatives and methods of useAMGEN INC·Filed 2002·Granted Sep 5, 2006·49 cites·20 claims
- 2489US8088794B2Substituted amide derivatives and methods of useKIM TAE-SEONG·Filed 2010·Granted Jan 3, 2012·14 cites·14 claims
- 2589US7759344B2Bis-aryl amide derivatives and methods of useAMGEN INC·Filed 2008·Granted Jul 20, 2010·15 cites·12 claims
- 2688US2025381187A1Kras g12c inhibitors and methods of using the sameAMGEN INC·Filed 2025·Application pending·0 cites
- 2786US8642624B2Substituted alkylamine derivatives and methods of useCHEN GUOQING·Filed 2011·Granted Feb 4, 2014·11 cites·3 claims
- 2886US7687522B2Substituted pyridines and pyrimidines and their use in treatment of cancerAMGEN INC·Filed 2007·Granted Mar 30, 2010·8 cites·3 claims
- 2985US7101868B2Substituted arylamine derivatives and methods of useAMGEN INC·Filed 2004·Granted Sep 5, 2006·20 cites·36 claims
- 3085US2025362134A1Kras g12c inhibitors and methods of using the sameAMGEN INC·Filed 2025·Application pending·0 cites
- 3184US11845760B2PRMT5 inhibitorsAMGEN INC·Filed 2021·Granted Dec 19, 2023·1 cites·46 claims
- 3284US2024174660A1Kras g12c inhibitors and methods of using the sameAMGEN INC·Filed 2023·Application pending·0 cites
- 3384US2024287068A1Inhibitors of kras g12c and methods of using the sameAMGEN INC·Filed 2024·Application pending·0 cites
- 3483US8685983B2Method of treating cancer with substituted amide derivativesKIM TAE-SEONG·Filed 2011·Granted Apr 1, 2014·7 cites·5 claims
- 3583US8017601B2Bis-aryl kinase inhibitors and methodAMGEN INC·Filed 2006·Granted Sep 13, 2011·7 cites·18 claims
- 3683US7915287B2Substituted heterocycles and methods of useAMGEN INC·Filed 2007·Granted Mar 29, 2011·4 cites·21 claims
- 3782US2025057817A1Kras g12c inhibitors and methods of using the sameAMGEN INC·Filed 2024·Application pending·0 cites
- 3880US8772480B2Inhibitors of PI3 kinase and/or mTORAMGEN INC·Filed 2012·Granted Jul 8, 2014·5 cites·25 claims
- 3976US2025304599A1Macrocyclic compounds and methods of useAMGEN INC·Filed 2024·Application pending·0 cites
- 4074US2022168280A1Kras g12c inhibitors and methods of using the sameAMGEN INC·Filed 2022·Application pending·0 cites
- 4172US9365522B2Pyrazole amide derivativeAMGEN INC·Filed 2015·Granted Jun 14, 2016·2 cites·14 claims
- 4270US8415376B2Inhibitors of PI3 kinaseBO YUNXIN Y·Filed 2009·Granted Apr 9, 2013·1 cites·9 claims
- 4370US7626030B2Compounds and methods of useAMGEN INC·Filed 2005·Granted Dec 1, 2009·1 cites·25 claims
- 4470US2020055845A1Kras g12c inhibitors and methods of using the sameAMGEN INC·Filed 2019·Application pending·0 cites
- 4569US2025236631A1Macrocyclic compounds and methods of useAMGEN INC·Filed 2025·Application pending·0 cites
- 4669US2024092794A1Novel prmt5 inhibitorsAMGEN INC·Filed 2023·Application pending·0 cites
- 4766US8178557B2Compounds and methods of usePOTASHMAN MICHELE·Filed 2008·Granted May 15, 2012·1 cites·21 claims
- 4858US2013273004A1Substituted alkylamine derivatives and methods of useAMGEN INC·Filed 2013·Application pending·0 cites
- 4957US2005153960A1Substituted arylamine derivatives and methods of useAMGEN INC·Filed 2004·Application pending·0 cites
- 5054US2024124442A1Tricyclic-amido-bicyclic prmt5 inhibitorsAMGEN INC·Filed 2022·Application pending·0 cites
Showing the top 50 of 56 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →